Apollo Strategic Growth Capital II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as APH I (Sub I), Ltd. and changed its name to Apollo Strategic Growth Capital II in December 2020. Apollo Strategic Growth Capital II was incorporated in 2008 and is based in New York, New York.
IPO Year: 2021
Exchange: NYSE
Website: apollostrategicgrowthcapitalii.com
| Date | Price Target | Rating | Analyst |
|---|
NEW YORK, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Apollo Strategic Growth Capital II (NYSE:APGB) (the "Company"), a publicly-traded special purpose acquisition company, today announced that it will liquidate and dissolve the Company in accordance with the provisions of the Company's fourth amended and restated memorandum and articles of association, as amended (the "Amended and Restated Memorandum and Articles of Association"). Accordingly, the Company will redeem all of its outstanding Class A ordinary shares, par value $0.00025 (the "public shares"), effective as of November 28, 2023. As stated in the Amended and Restated Memorandum and Articles of Association, if the Company is unable to com
Cushman & Wakefield (NYSE:CWK) today announced the appointment of Angela Sun to its Board of Directors. Sun is a Partner at Rise Health Group, a digital health company. Sun will join the Board as an independent director on November 1, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210809005378/en/Angela Sun (Photo: Business Wire) "Angela's years of experience serving on boards and working across a diverse range of sectors, including data and technology, financial services, government and healthcare, will prove extremely valuable to our firm as we strive to provide innovative solutions to our clients. We are pleased to welco
Apollo Strategic Growth Capital II (NYSE:APGB) (the "Company"), a publicly-traded special purpose acquisition company, today announced that it will liquidate and dissolve the Company in accordance with the provisions of the Company's fourth amended and restated memorandum and articles of association, as amended (the "Amended and Restated Memorandum and Articles of Association"). Accordingly, the Company will redeem all of its outstanding Class A ordinary shares, par value $0.00025 (the "public shares"), effective as of November 28, 2023. As stated in the Amended and Restated Memorandum and Articles of Association, if the Company is unable to complete an initial business combination by Februa
- SEC Form 8 Filing
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G/A - Apollo Strategic Growth Capital II (0001838337) (Subject)
SC 13G - Apollo Strategic Growth Capital II (0001838337) (Subject)
Cushman & Wakefield (NYSE:CWK) today announced the appointment of Angela Sun to its Board of Directors. Sun is a Partner at Rise Health Group, a digital health company. Sun will join the Board as an independent director on November 1, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210809005378/en/Angela Sun (Photo: Business Wire) "Angela's years of experience serving on boards and working across a diverse range of sectors, including data and technology, financial services, government and healthcare, will prove extremely valuable to our firm as we strive to provide innovative solutions to our clients. We are pleased to welco
4 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
3 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
4 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
4 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
4 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
4 - Apollo Strategic Growth Capital II (0001838337) (Issuer)
15-12G - Apollo Strategic Growth Capital II (0001838337) (Filer)
25-NSE - Apollo Strategic Growth Capital II (0001838337) (Subject)
10-Q - Apollo Strategic Growth Capital II (0001838337) (Filer)
8-K - Apollo Strategic Growth Capital II (0001838337) (Filer)
10-Q - Apollo Strategic Growth Capital II (0001838337) (Filer)
10-Q - Apollo Strategic Growth Capital II (0001838337) (Filer)
8-K - Apollo Strategic Growth Capital II (0001838337) (Filer)
8-K - Apollo Strategic Growth Capital II (0001838337) (Filer)
DEFA14A - Apollo Strategic Growth Capital II (0001838337) (Filer)
8-K - Apollo Strategic Growth Capital II (0001838337) (Filer)